Sweden has demonstrated that a single gene therapy injection can restore hearing in people born with a genetic form of deafness, offering a potential long-term treatment.
A personalised immune cell therapy has successfully treated three life-threatening autoimmune diseases in a single patient, offering new hope for tackling complex immune disorders.
In Japan, a newly approved stem cell therapy is offering fresh hope for people with Parkinson’s disease by aiming to replace the brain cells responsible for movement.
Chile has become the first country in the Americas verified to eliminate leprosy as a public health problem, marking more than three decades without locally transmitted cases.
The United Kingdom has used a pioneering gene therapy that reprogrammes immune cells to hunt cancer, helping patients with previously untreatable blood cancer achieve lasting remission.
Scientists have discovered that astrocytes, once thought to merely support neurons, actively regulate brain activity and influence mental and emotional states.
In the UK, a breakthrough “living drug” has been given to an NHS patient with aggressive leukaemia, opening access to a powerful personalised therapy that can deliver long-term remission and potential cures.
Scientists have developed a new generation of immune cells that could transform cancer therapy. This breakthrough could make rapid, off-the-shelf treatments possible.
Scientists have unveiled the first-ever treatment that makes a real impact on Huntington’s disease — a genetic neurodegenerative disorder once seen as untreatable.
The World Health Organization has added vital treatments for cancer, diabetes, and obesity to its Essential Medicines Lists — a move that will make groundbreaking therapies more widely available worldwide.
